Crossmark

Data Integrity in the Pharmaceutical Industry: Analysis of Inspections and Warning Letters Issued by the Bioresearch Monitoring Program Between Fiscal Years 2007–2018

Crossref DOI link: https://doi.org/10.1007/s43441-020-00129-z

Published Online: 2020-02-24

Published Print: 2020-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rogers, Clinton A.

Ahearn, Jennifer D.

Bartlett, Michael G. https://orcid.org/0000-0003-0626-3234
License Information

Text and Data Mining valid from 2020-02-24

Version of Record valid from 2020-02-24
More Information

Article History

Received: 12 December 2019

Accepted: 9 February 2020

First Online: 24 February 2020

Compliance with Ethical Standards

:

: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

Document is current

Any future updates will be listed below